Tarceva Receives Positive EU Opinion For The Treatment Of Metastatic Pancreatic Cancer
Thu, 28 Dec 2006 08:00 AM EST
... Roche announced today that its oral cancer medicine Tarceva (erlotinib) has received a positive recommendation from the European Committee for Medicinal Products for Human Use (CHMP) following a re-examination of the data supporting the filing of Tarceva in metastatic pancreatic cancer. [click link for full article] ...

Not Signed In -


